Firalis SAS - Product Pipeline Analysis, 2014 Update

Date: June 26, 2014
Pages: 21
Price:
US$ 750.00
License [?]:
Publisher: GlobalData
Report type: Strategic Report
Delivery: E-mail Delivery (PDF)
ID: F5BC7561FBCEN
Leaflet:

Download PDF Leaflet

Firalis SAS - Product Pipeline Analysis, 2014 Update
Summary

Firalis SAS (Firalis) is a biotechnology company. The company discovers and develops biomarkers and biomarker-based diagnostic kits to improve disease outcomes and patient comfort. Its products include immunoassays, cardiovascular arrays, and other products. Firalis provides services such as biomarker discovery, biomarker assay development, sample storage, biomarker analytical services, protein and antibody arrays, biomarker data analysis and biomarker qualification services. It partners with IGBMC, Jubilant Biosys, Urolead, Universite Pierre ET Marie Curie, University of Freiburg, IMTEK, University of Franche-Comte and CRP-Sante, among others. Firalis is headquartered in Huningue, Haute Normandie, France.

This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.

Scope:
  • The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
  • The report analyzes all pipeline products in development for the company Firalis SAS
  • The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
  • The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
  • The report provides detailed description of products in development, technical specification and functions
  • The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.
Reasons to Buy:
  • Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
  • Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
  • To formulate effective Research & Development strategies
  • Develop market-entry and market expansion strategies
  • Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
  • Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Develop competition strategies by identifying the status and likely launch of the competitors’ pipeline products through review of the clinical trials, stage and of development, etc
  • Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio
Firalis SAS Company Snapshot
Firalis SAS Company Overview
Key Information
Firalis SAS Pipeline Products and Clinical Trials Overview
Firalis SAS – Pipeline Analysis Overview
Key Facts
Firalis SAS - Major Products and Services
Firalis SAS Pipeline Products by Development Stage
Firalis SAS Pipeline Products Overview
Diagnostic Assay - Cardiovascular Diseases
Diagnostic Assay - Cardiovascular Diseases Product Overview
Diagnostic Kit - Acute Myocardial Infarction
Diagnostic Kit - Acute Myocardial Infarction Product Overview
Diagnostic Kit - Coxibs and NSAIDs
Diagnostic Kit - Coxibs and NSAIDs Product Overview
Diagnostic Kit - Drug Induced Vasculitis
Diagnostic Kit - Drug Induced Vasculitis Product Overview
Diagnostic Panel - Vasculitis
Diagnostic Panel - Vasculitis Product Overview
Micro-ELISA System
Micro-ELISA System Product Overview
Firalis SAS - Key Competitors
Firalis SAS - Key Employees
Firalis SAS - Locations And Subsidiaries
Head Office
Recent Developments
Firalis SAS, Recent Developments
Jan 09, 2014: Firalis Expands Service Offerings via New Bioanalytical Platform
Dec 24, 2013: Firalis launched a range of CE marked immunoassays for the titration of cardiovascular markers
Appendix
Methodology
About GlobalData
Contact Us
Disclaimer

LIST OF TABLES

Firalis SAS, Key Facts
Firalis SAS Pipeline Products and Clinical Trials Overview
Firalis SAS Pipeline Products by Equipment Type
Firalis SAS Pipeline Products by Indication
Firalis SAS, Key Facts
Firalis SAS, Major Products and Services
Firalis SAS Number of Pipeline Products by Development Stage
Firalis SAS Pipeline Products Summary by Development Stage
Diagnostic Assay - Cardiovascular Diseases - Product Status
Diagnostic Assay - Cardiovascular Diseases - Product Description
Diagnostic Kit - Acute Myocardial Infarction - Product Status
Diagnostic Kit - Acute Myocardial Infarction - Product Description
Diagnostic Kit - Coxibs and NSAIDs - Product Status
Diagnostic Kit - Coxibs and NSAIDs - Product Description
Diagnostic Kit - Drug Induced Vasculitis - Product Status
Diagnostic Kit - Drug Induced Vasculitis - Product Description
Diagnostic Panel - Vasculitis - Product Status
Diagnostic Panel - Vasculitis - Product Description
Micro-ELISA System - Product Status
Micro-ELISA System - Product Description
Firalis SAS, Key Employees

LIST OF FIGURES

Firalis SAS Pipeline Products by Equipment Type
Firalis SAS Pipeline Products by Development Stage
Skip to top


Ask Your Question

Firalis SAS - Product Pipeline Analysis, 2014 Update
Company name*:
Contact person*:
Phone/fax*:
Email*:
Request invoice
Your enquiry:
Please click on a Check Box below to confirm you are not a robot: